From Liston Street Pulse:
Regeneron Pharmaceuticals, Inc. (REGN) has recently got the number 40 spot at the analysts S&P 500 ranking. The company has taken over EOG, which previously had the spot. The ranking is based on the opinion of analysts from various brokerage houses. These are tallied and averaged and other components are […]
The post Regeneron #40 in Analysts Ranking appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015